Autres langues GlaxoSmithKline Pakistan Limited

Actions

GLAXO

PK0001301016

Produits pharmaceutiques

Cours en clôture Pakistan S.E. 12/08/2026			Varia. 5j.	Varia. 1 janv.
345,43 ^PKR	+0,14%		-1,55%	-11,38%

03/08	GlaxoSmithKline Pakistan Limited annonce la nomination de Hasham Ali Baber en tant qu'administrateur non exécutif, à compter du 30 juillet 2026	CI
08/06	GlaxoSmithKline Pakistan Limited annonce la démission de Hasham Baber de son poste de directeur exécutif du conseil d'administration, effective au 30 juin 2026	CI

Autres langues

03/08	GlaxoSmithKline Pakistan : Appointment of Interim/ Acting Chief Financial Officer
03/08	GlaxoSmithKline Pakistan : Appointment of Non-Executive Director
03/08	GlaxoSmithKline Pakistan Limited Appoints Umair Majeed as Interim/Acting Chief Financial Officer, Effective from July 30, 2026
03/08	GlaxoSmithKline Pakistan Limited Announces Appointment of Hasham Ali Baber as Non-Executive Director, Effective July 30, 2026
08/06	GlaxoSmithKline Pakistan Limited Announces Resignation of Hasham Baber as Chief Financial Officer, Effective June 30, 2026
08/06	GlaxoSmithKline Pakistan Limited Announces Resignation of Hasham Baber as Executive Director of the Board of Directors, Effective June 30, 2026
01/06	GlaxoSmithKline Pakistan : Resignation of Non-Executive Director
01/06	GlaxoSmithKline Pakistan Limited Announces Resignation of Ana Paula De Freitas Passos as Non-Executive Director, Effective May 31, 2026
25/05	GlaxoSmithKline Pakistan : (Re) Appointment of Chairperson and Chief Executive Officer
08/05	GlaxoSmithKline Pakistan : Video Recording of the Corporate Briefing Session
05/05	GlaxoSmithKline Pakistan : Presentation of the Corporate Briefing Session
30/04	GlaxoSmithKline Pakistan : Corporate Briefing Session
30/04	GlaxoSmithkline Pakistan Limited Approves Final Cash Dividend for the Year Ended 31 December, 2025
30/04	GlaxoSmithkline Pakistan Limited Approves Board Elections, Effective May 25, 2026
27/04	GlaxoSmithKline Pakistan Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
20/04	GlaxoSmithKline Pakistan : Board Meeting Quarter 1- 2026
09/04	GlaxoSmithKline Pakistan : Transmission of Annual Financial Statements for the year ended 31-12-2025
09/04	GlaxoSmithKline Pakistan Limited Proposes Final Cash Dividend for the Financial Year Ended 31 December 2025
08/04	GlaxoSmithKline Pakistan : Prior Publication of Annual General Meeting Notice
07/04	GlaxoSmithKline Pakistan Limited Announces Board Changes
06/04	GlaxoSmithKline Pakistan : Change in book closure date for the 79th AGM
31/03	GlaxoSmithKline Pakistan Limited Announces Resignation of Lai Kuen Goh as Chairperson and Non-Executive Director, with Effect from March 31, 2026
26/03	GlaxoSmithKline Pakistan Limited Reports Earnings Results for the Full Year Ended December 31, 2025
18/03	GlaxoSmithKline Pakistan : Board Meeting Quarter 4, 2025
05/12	GlaxoSmithKline Pakistan : Presentation for Corporate Briefing Session -2025